Przejdź do zawartości
Merck

Mechanism of action of dextromethorphan/quinidine:comparison with ketamine.

CNS spectrums (2013-09-21)
Stephen M Stahl
ABSTRAKT

Reports of rapid-onset but short-duration antidepressant effects in patients with treatment-resistant mood disorders after intravenous administration of ketamine have prompted efforts to find an agent with ketamine's properties that can be administered orally in repeated doses in order to sustain that action. One candidate for this dextromethorphan, and here the pharmacologic mechanism of action is compared and contrasted with that of ketamine.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Dextromethorphan hydrobromide monohydrate, ≥99% (TLC)
Dextromethorphan hydrobromide, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Quinidine, anhydrous
Sigma-Aldrich
(±)-Ketamine hydrochloride, solid
Supelco
Dextromethorphan solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Dextromethorphan HBr, certified reference material
Sigma-Aldrich
Dextromethorphan hydrobromide, meets USP testing specifications
Sigma-Aldrich
Quinidine, crystallized, ≥98.0% (dried material, NT)
Supelco
Ketamine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®